Group B Streptococcus vaccination in pregnancy: Moving toward a global maternal immunization program

Vaccine

Volumn 31, Issue S4, 2013, Pages

  Munoz, Flor M ^a   Ferrieri, Patricia ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Global program; Group B streptococcus; Maternal immunization; Neonates; Pregnancy; Vaccine

Indexed keywords

INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; STREPTOCOCCUS VACCINE; TETANUS TOXOID;

2009 H1N1 INFLUENZA; ACTIVE IMMUNIZATION; ANTIBIOTIC PROPHYLAXIS; ANTIBODY RESPONSE; BACTERIAL COLONIZATION; DEVELOPING COUNTRY; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; GROUP B STREPTOCOCCAL INFECTION; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; IMMUNIZATION; MEDICAL DOCUMENTATION; NEISSERIA MENINGITIDIS; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN TETANUS; PATIENT COMPLIANCE; PERINATAL PERIOD; PLACENTAL TRANSFER; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SERUM BACTERICIDAL ANTIBODY ASSAY; SPONTANEOUS ABORTION; STILLBIRTH; TETANUS PROPHYLAXIS;

AAFP; AAP; ACIP; ACOG; ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES; AMERICAN ACADEMY OF FAMILY PRACTICE; AMERICAN ACADEMY OF PEDIATRICS; AMERICAN COLLEGE OF OBSTETRICS AND GYNECOLOGY; CDC; CENTERS FOR DISEASE CONTROL AND PREVENTION; EPI; EXTENDED PROGRAM ON IMMUNIZATION; GACVS; GAVI; GBS; GLOBAL ADVISORY COMMITTEE ON VACCINE SAFETY; GLOBAL ALLIANCE FOR VACCINES AND IMMUNISATION; GLOBAL PROGRAM; GROUP B STREPTOCOCCUS; MATERNAL IMMUNIZATION; MATERNAL-NEONATAL TETANUS; MNT; NEONATES; PREGNANCY; VACCINE; WHO; WORLD HEALTH ORGANIZATION;

FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFLUENZA VACCINES; MASS VACCINATION; MENINGOCOCCAL VACCINES; PERTUSSIS VACCINE; PREGNANCY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE; TETANUS TOXOID;

EID: 84883049944     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.11.026     Document Type: Review

References (42)

1. American College of Obstetricians and Gynecologists' immunization web site. Available at http://www.immunizationforwomen.org/.
2. Centers for Disease Control and Prevention's Immunizations for Pregnant Women. Available at http://www.cdc.gov/vaccines/parents/pregnant.html.
3. Diphtheria, tetanus, and pertussis, recommendations for vaccine use and other preventive measures. MMWR August 8, 1991, 40(RR-10).
4. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR January 14, 2011, 60(01):13-15.
5. WHO Tetanus vaccine position paper. Wkly Epidemiol Rec 2006, 20:197-208.
6. WHO Influenza vaccines position paper. Wkly Epidemiol Rec 2005, 33:279-287.
7. WHO Meningococcal vaccines: WHO position paper. Wkly Epidemiol Rec November 2011, 47:521-540.
8. Global Advisory Committee on Vaccine Safety Wkly Epidemiol Rec June 2012, 30:281-287.
9. Schofield F.D., Tucker V.M., Westbrook G.R. Neonatal tetanus in New Guinea, effect of active immunization in pregnancy. Br Med J 1961, 2(5255):785-789.
10. World Health Organization (WHO) Maternal and Neonatal Tetanus (MNT) elimination. WHO website http://www.who.int/immunization_monitoring/diseases/MNTE_initiative/en/.
11. Harris J.W. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA 1919, 72:978-980.
12. Freeman D.W., Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959, 78:1172-1175.
13. Abdel-Ghafar A.N., Chotpitayasunondh T., Zhangcheng G., Hayden F.G., Nguyen D.H., deJong M.D., et al. Update on avian influenza A (H1N1) virus in humans. N Engl J Med 2008, 358:261-273.
14. Gu J., Xie Z., Gao Z., Liu J., Korteweq C., Ye J., et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007, 370:1137-1145.
15. Ng W.F., To K.F. Pathology of human H5N1 infection: new findings. Lancet 2007, 370:1106-1108.
16. Neuzil K.M., Reed G.W., Mitchel E.F., Simonsen L., Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations for pregnant women. Am J Epidemiol 1998, 148(1):1094-1102.
17. Hartert T.V., Neuzil K.M., Shintani A.K., Mitchel E.F., Snowden M.S., Wood L.B., et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 2003, 189(6):1705-1712.
18. Lindsay L., Jackson L.A., Savitz D.A., Weber D.J., Koch G.G., Kong L., et al. Community influenza activity and risk of acute influenza like illness episodes among healthy unvaccinated pregnant and post-partum women. Am J Epidemiol 2006, 163(9):838-848.
19. Jamieson D.J., Rasmussen S.A., Uyeki T.M., Weinbaum C. Pandemic influenza and pregnancy revisited: lessons learned from the 2009 pandemic influenza A (H1N1). Am J Obstet Gynecol 2011, 204(6 Suppl. 1):S1-S3.
20. Siston A.M., Rasmussen S.A., Honein M.A., Fry A.M., Seib K., Callaghan W.M., et al. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAMA 2010, 303(15):1517-1525.
21. Louie J.K., Acosta M., Jamieson D.J., Honein M.A. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010, 362(1):27-35. California Pandemic (H1N1) Working Group.
22. Influenza vaccination during pregnancy. Committee Opinion No. 468. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010, 116:1006-1007.
23. WHO Global Advisory Committee on Vaccine Safety Influenza vaccination of women during pregnancy. Wkly Epidemiol Rec January 2004, 79:17.
24. Strategic Advisory Group of Experts (SAGE). Global alert and response. Experts advise WHO on vaccine policies and strategies. Pandemic (H1N1) 2009 briefing note 14; October 2009. http://www.who.int/csr/disease/swineflu/notes/briefing_20091030/en/.
25. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359:1555-1564. [published erratum appears in N Engl J Med 2009; 360:648].
26. Eick A.A., Uyeki T.M., Klimov A., Hall H., Reid R., Santosham M., et al. Maternal influenza vaccination and effect of influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011, 65(2):E1-E8.
27. WHO Meningitis A conjugate vaccine. Wkly Epidemiol Rec 2011, 5:42-43.
28. WHO Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010, 40:385-400.
29. Healy C.M., Munoz F.M., Rench M.A., Halasa N.B., Edwards K.M., Baker C.J. Prevalence of pertussis antibodies in maternal delivery, cord and infant serum. J Infect Dis 2004, 190:335-340.
30. Murphy T.V., Slade B.A., Broder K.R., Kretsinger K., Tiwari T., Joyce P.M., et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR May 30, 2008, 57(RR-4):1-51.
31. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine in pregnant women and persons who have or anticipate having close contact with an infant aged less than 12 months - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011, 60(41):1424-1426.
32. Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Committee Opinion No. 521. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012, 119:690-691.
33. Cohen P., Scadron S.J. The effects of active immunization of the mother upon the offspring. J Pediatr 1946, 29:609-619.
34. Gall S.A., Myers J., Pichichero M. Maternal immunization with tetanus diphtheria pertussis vaccine: effect on maternal and neonatal serum antibodies. Am J Obstet Gynecol 2011, 204(4):334.e1-334.e5.
35. CDC Prevention of perinatal group B streptococcal disease, revised guidelines from CDC, 2010. MMWR 2010, 59(RR-10).
36. Berardi A., Lugli L., Rossi C., China M.C., Vellani G., Contiero R., et al. Neonatal bacterial meningitis. Minerva Pediatr 2010, 62(Suppl. 1):51-54.
37. Heath P.T., Balfour G., Weisner A.M., Efstratiou A., Lamagni T.L., Tighe H., et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004, 363:292-294.
38. Isaacs D., Royle J.A. Intrapartum antibiotics and early onset neonatal sepsis caused by group B streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections. Pediatr Infect Dis J 1999, 18:524-528.
39. Dagnew A.F., Cunnington M.C., Dube Q., Edwards M.S., French N., Heyderman R.S., et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis 2012, 55(1):91-102.
40. Baker C.J., Kasper D.L. Vaccination as a measure for prevention of neonatal GBS infection. Antibiot Chemother 1985, 35:281-290.
41. Baker C.J., Rench M.A., McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003, 21(24):3468-3472.
42. GPV policy statement. Geneva: World Health Organization; 1996. WHO/VSQ/GEN/96.02 Rev. 1. Available at http://www.who.int/vaccines-documents/DocsPDF/www9637.pdf.